Evidence map›Paper›PMID 12886021›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2003

Clusterin as a biomarker in murine and human intestinal neoplasia.

Xiaodi Chen, Richard B Halberg, William M Ehrhardt, Jose Torrealba, William F Dove

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 133 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. The role of Clusterin in cancer metastasis.Cancer management and research · 2019
    Article
  15. Article
  16. Article
  17. Mouse models of colorectal cancer as preclinical models.BioEssays : news and reviews in molecular, cellular and developmental biology · 2015
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xiaodi ChenMcArdle Laboratory for Cancer Research, University of Wisconsin, Madison, WI 53706, USA.
Richard B Halberg
William M Ehrhardt
Jose Torrealba
William F Dove
University of Wisconsin–Madison · US

Funding

GENES CONTROLLING NEOPLASIA OF THE INTESTINAL EPITHELIUMR37CA063677 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI DOVE, WILLIAM FRANKLIN · 1998 to 2008
$6.3M
MOUSE MODELS FOR HUMAN CANCERU01CA084227 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI DOVE, WILLIAM FRANKLIN · 1999 to 2003
$1.9M
CELL CYCLE, DEVELOPMENT, AND NEOPLASIAR01CA063677 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI DOVE, WILLIAM FRANKLIN · 1993 to 2012
$1.4M
NCI NIH HHS CA63677NCI NIH HHS R01 CA063677NCI NIH HHS R37 CA063677NCI NIH HHS U01-CA84227
6 · The paper itself

Abstract

Early detection of colorectal cancer is critical for the management of this disease. Biomarkers for early detection of several cancers have been developed and applied clinically in recent years. We have sought to discover candidate biomarkers without the restricted choice of markers placed on microarrays, and without the biological complications of genetic and environmental heterogeneity. We have compared by cDNA subtraction two genetically matched sets of mice, one developing multiple intestinal neoplasia (C57BL/6J-ApcMin) and the other tumor-free (C57BL/6J). One prominent candidate biomarker, clusterin, was then subjected to a series of validation steps. In situ hybridization and immunohistochemistry were used to analyze clusterin expression at a cellular level on a series of murine intestinal and human colonic neoplasms. Elevated clusterin expression was characterized within certain regions of murine and human tumors regardless of tumor stage, location, or mode of initiation. The cells showing high clusterin levels generally lacked differentiation markers and adenomatous polyposis coli antigen. Tumor cells undergoing apoptosis expressed low levels of clusterin. Its specific expression patterns and correlation with cellular events during tumorigenesis make it a useful diagnostic tool in the mouse and a potential contributor to the set of biomarkers for early detection of human colon cancer.

Indexed as

Biomarkers, TumorAlkylating AgentsAnimalsApoptosisCell DifferentiationCell DivisionClusterinColonic NeoplasmsDNA, ComplementaryEthylnitrosoureaGenotypeGlycoproteinsHeterozygoteHumansImmunohistochemistryIn Situ HybridizationAlkylating AgentsBiomarkers, TumorCLU protein, humanClu protein, mouseClusterinDNA, ComplementaryEthylnitrosoureaGlycoproteinsMolecular ChaperonesRNA, Messenger

Identifiers

PMID12886021
PMCPMC170952
OpenAlexW2074978845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.